Literature DB >> 11328284

Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism.

E Moir1, N A Booth, B Bennett, L A Robbie.   

Abstract

Many human thrombi lyse spontaneously without the administration of lytic drugs and cause no clinical symptoms. The mechanisms by which this occurs are incompletely understood. We found that model thrombi prepared from whole human blood in a Chandler loop also exhibited significant spontaneous lysis. Lysis was inhibited by chemical protease inhibitors, consistent with proteolysis resulting primarily from serine proteases, with a small contribution from matrix metalloproteinases. Whole blood was fractionated into platelet-rich plasma and cell populations. Significant spontaneous lysis was observed in platelet-rich thrombi enriched with polymorphonuclear leucocytes (PMNs), whereas mononuclear cells (MCs) and erythrocytes did not contribute to lysis. Incorporation of antibodies to urokinase (u-PA) and its receptor u-PAR neutralized a large proportion of the activity. Incubation of plasma with PMNs generated free u-PA activity, which was also detectable in model thrombi and in vivo human thrombi. Purified neutrophils, free of eosinophils, generated activity identical to PMNs. Smaller contributions to lysis by tissue-type plasminogen activator (t-PA), elastase and cathepsin G were also identified. These findings suggest a major role for circulating PMNs in endogenous thrombus lysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328284     DOI: 10.1046/j.1365-2141.2001.02696.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

2.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Enhanced spontaneous thrombolysis: a new therapeutic challenge.

Authors:  I B Kovacs; D A Gorog; J Yamamoto
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

4.  Neutrophils Mediate Pulmonary Artery Thrombosis In Situ.

Authors:  Olga Porembskaya; Vsevolod Zinserling; Vladimir Tomson; Yana Toropova; Eleonora A Starikova; Vitaliy V Maslei; Nika I Bulavinova; Olga V Kirik; Marina A Syrtsova; Leonid Laberko; Maxim I Galchenko; Vyacheslav Kravchuk; Sergey Saiganov; Alexander Brill
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

5.  Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.

Authors:  N J Mutch; J S Koikkalainen; S R Fraser; K M Duthie; M Griffin; J Mitchell; H G Watson; N A Booth
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

6.  The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.

Authors:  Catherine P M Hayward; Minggao Liang; Subia Tasneem; Asim Soomro; John S Waye; Andrew D Paterson; Georges E Rivard; Michael D Wilson
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

Review 7.  Fibrinolysis and Inflammation in Venous Thrombus Resolution.

Authors:  Subhradip Mukhopadhyay; Tierra A Johnson; Nadire Duru; Marguerite S Buzza; Nisha R Pawar; Rajabrata Sarkar; Toni M Antalis
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

8.  Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.

Authors:  Claire S Whyte; Hadj Ahmed Mostefai; Kim M Baeten; Andrew J Lucking; David E Newby; Nuala A Booth; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.